UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B
HealthcareAdd-on
UCB→Neurona Therapeutics
Apr 17, 2026
Gilead Receives Regulatory Approvals for Arcellx Deal
Announced
HealthcareOther
Deal Overview
Gilead received all required regulatory approvals for its acquisition of Arcellx and extended its tender offer. The update indicates the transaction is moving forward through remaining closing conditions.
The excerpt provides no deal consideration or pricing details, but it confirms regulatory clearance and a continued tender process.
Key Details
- Transaction
- Gilead acquires Arcellx
Powered by Tentt
Source healthcare deals for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Related Deals
Florida system raises $100M for new ED
HealthcareFloridaOther
Jackson Memorial Hospital
Apr 17, 2026
Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs
HealthcareOther
Kailera Therapeutics
Apr 17, 2026
Panthera Biopartners Expands European Footprint with Acquisition of Hungary’s Leading Clinical Research Organisation OEC - EIN Presswire
HealthcarePlatform
Panthera Biopartners→OEC
Apr 17, 2026
Centessa Pharmaceuticals plc — SEC PREM14A Filing
HealthcareMerger
Lilly→Centessa Pharmaceuticals
Apr 17, 2026